AstraZeneca pauses £200m Cambridge investment
Mitchell LabiakBusiness reporter andSimon JackBusiness editorGetty ImagesAstraZeneca has paused plans to invest £200m at a Cambridge research site in a fresh blow to the UK pharmaceutical industry.The project, which was…
